Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction
about
Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015)Stem cell therapy for heart failure: Ensuring regenerative proficiencyEnergy metabolism plasticity enables stemness programsMesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac diseaseCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsRegenerative principles enrich cardiac rehabilitation practiceThe stuttering progress of cell therapy for heart diseaseCell therapy for cardiac repair--lessons from clinical trials.Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative MedicineRegenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS CardiomyopathyStem cells for cardiac repair in acute myocardial infarction.Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21.Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cellsCardiac stem cell therapy for cardiac repair.Aprotinin extends mechanical integrity time of cell-seeded fibrin sutures.Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemiaInhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy.Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction.Cardiac muscle regeneration: lessons from development.Circulating very small embryonic-like stem cells in cardiovascular disease.Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept studyOptimized delivery system achieves enhanced endomyocardial stem cell retention.The time window for therapy with peptide nanofibers combined with autologous bone marrow cells in pigs after acute myocardial infarction."Second-generation" stem cells for cardiac repairEffect of fatty acids on human bone marrow mesenchymal stem cell energy metabolism and survival.Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosaConcomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial InfarctionPostinfarction Functional Recovery Driven by a Three-Dimensional Engineered Fibrin Patch Composed of Human Umbilical Cord Blood-Derived Mesenchymal Stem CellsPreconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of ratsBone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potentialInduction of cardiac myogenic lineage development differs between mesenchymal and satellite cells and is accelerated by bone morphogenetic protein-4.Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells.Differentiation of Bone Marrow Mesenchymal Stem Cells to Cardiomyocyte-Like Cells Is Regulated by the Combined Low Dose Treatment of Transforming Growth Factor-β1 and 5-Azacytidine.A novel suture-based method for efficient transplantation of stem cells.A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarctionEndometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic.Differentiation of Rat bone marrow Mesenchymal stem cells into Adipocytes and Cardiomyocytes after treatment with platelet lysateDiscrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Cardiac Repair and Regeneration: The Value of Cell Therapies.
P2860
Q26748751-EDAF2243-2BE9-4BF9-9901-147E430B9410Q26750516-A8A863C8-5E7E-4EDA-8609-B15350BC64F9Q26822945-7FDE94BA-D7BD-4D5C-934D-B7BE68287D97Q26865070-1BA1AA60-FDFA-4A54-B812-A920A0B4EDE7Q27001159-499EBC0E-B863-4839-84BE-A9B290CCBDD3Q27022906-2AEE1467-5BDC-4DFC-8DD1-7148F4DC09C9Q28247457-2593CEA8-A4C5-41E9-B2CE-D500538E85C6Q30359782-6EB6A043-4AEE-4840-B986-615A46473959Q30390768-13C4C1F5-A334-4A89-833B-AFBA5B210FCAQ30401047-B1194E26-0E5E-499C-BF02-97B2EA67A873Q33352048-D6CA6A73-EF62-47F3-ABC6-6C5C11F28C12Q33722181-35125ABB-D213-40B5-AF06-D395163122E7Q33746224-D0DD01E5-A09C-47D4-AF88-5C0F050307FAQ33749374-48128912-A827-475C-B16A-2780399122D4Q33813957-6E17DF3A-921A-4D38-8BAC-767659FAE7EBQ34218250-5CD89CD6-B335-4EEE-A3FC-93B397D04AD2Q34232257-D83BC821-DEDC-44A2-85BA-B4E0F07D727EQ34338022-416EFB76-3743-4CA5-9E16-2ED61781BF2DQ34588417-51DCBC7E-90BD-4349-BCC3-E5EB9BFC2F13Q34619426-7FFA1C27-E5E8-4EBB-A38B-207515687BBFQ34637607-E7E21FF6-6156-4932-AE1E-9FFD7342DEDFQ34756310-643928F6-0A75-41A5-957B-785B3C302FD2Q35165467-19D7C030-63B7-4693-858E-7265E2F1CC4EQ35205665-004E0355-A63B-474F-B92A-9542DF2D3F9FQ35576599-57552180-93AE-48C2-9384-2AEE7868F8A6Q35655462-7D87E5CD-84EC-4FCE-A44B-257138CA7D49Q35824554-ED9EB0AA-1D82-4750-87E7-422B329A5D31Q35878873-DDCA1B54-2AB9-4521-A8C8-B083BA67AF99Q35949645-AED08F05-0429-4551-B2FB-6C6A9100FC1AQ36181477-AFC51574-B9A7-416A-9DEF-1163BE4BE999Q36185568-AD7B6FCF-8105-46A4-827C-FEDF794C47DDQ36326979-AA53F8F0-499C-44C9-A208-372519E84D50Q36367015-8002799C-1AC9-4524-ABCD-542BCDFC4093Q36569428-CF57B7FD-51C7-4C53-8615-D37578BB6B7AQ36632891-013543D5-8E2F-4216-A184-78553E1DD86CQ36690614-AED78276-4ACA-4BAA-A132-50DEFBB59FE6Q36759570-B14CFEFF-495A-4830-A013-D4F51EBE3FA1Q36771430-5A68FDD6-4687-4BB9-8B60-4C58C4415DE7Q37016190-8F216334-3241-4EE6-92FB-99E193D9C6ABQ37152693-E97BCAD6-21CC-41D8-9BCD-DBB57DA2EB7D
P2860
Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Guided cardiopoiesis enhances ...... chronic myocardial infarction
@ast
Guided cardiopoiesis enhances ...... chronic myocardial infarction
@en
type
label
Guided cardiopoiesis enhances ...... chronic myocardial infarction
@ast
Guided cardiopoiesis enhances ...... chronic myocardial infarction
@en
prefLabel
Guided cardiopoiesis enhances ...... chronic myocardial infarction
@ast
Guided cardiopoiesis enhances ...... chronic myocardial infarction
@en
P2093
P2860
P1476
Guided cardiopoiesis enhances ...... chronic myocardial infarction
@en
P2093
Andre Terzic
Atta Behfar
Carmen Perez-Terzic
Christian Homsy
Jonathan J Nesbitt
Jozef Bartunek
Lois A Rowe
Ruben Crespo-Diaz
Satsuki Yamada
Vinciane Gaussin
P2860
P304
P356
10.1016/J.JACC.2010.03.066
P407
P577
2010-08-01T00:00:00Z